Management of Mild Coronary Atherosclerosis

Risk Stratification and Assessment

A coronary calcium score of 37 indicates mild coronary atherosclerosis, confirming subclinical atherosclerosis with measurable calcified plaque burden, and suggests the presence of both calcified and substantial non-calcified plaque, according to the Journal of Internal Medicine 1
The American College of Cardiology recommends that patients with a calcium score of 37 be considered at intermediate cardiovascular risk, with a higher risk compared to those with a zero calcium score 1

The American Heart Association recommends initiating high-intensity statin therapy to lower LDL-C, regardless of baseline cholesterol levels, for patients with a coronary calcium score of 37, as stated in JACC: Cardiovascular Imaging 2, 3
Additional medical therapy should include aspirin for antiplatelet therapy, ACE inhibitors or ARBs if hypertension or diabetes is present, and beta-blockers for symptom control if angina develops, as recommended by the American College of Cardiology 4
Aggressive modification of risk factors, including hypertension control, diabetes management, smoking cessation, and regular physical activity, is essential for patients with a coronary calcium score of 37, according to the Journal of Internal Medicine 1, 4

Patients with calcium scores in the 11-100 range have intermediate cardiovascular risk, and their 10-year risk for major adverse cardiovascular events (MACE) is elevated compared to zero calcium, but substantially lower than scores ≥400, as stated in the Journal of Internal Medicine 1

Repeat calcium scoring is generally not recommended for monitoring treatment response, as it doesn't regress with therapy, according to the Journal of Internal Medicine 1
Annual cardiovascular risk factor assessment and medication adherence monitoring are recommended, as well as regular follow-up with primary care or cardiology every 6-12 months, as stated in Praxis Medical Insights: Practical Summaries of Clinical Guidelines 4